The Preuss Foundation Seminar on Molecular Approaches to the Diagnosis and Treatment of Brain Tumors
December 2-4, 1992
Miami Beach, Florida
Darell Bigner, M.D., Ph.D.
Duke University Medical Center
Durham, North Carolina
R. Michael Blaese, M.D.
National Institutes of Health
Bethesda, Maryland
Antonino Cattaneo, Ph.D.
Institute of Neurobiology
Rome, Italy
Donald Coffey, Ph.D.
Johns Hopkins Hospital
Baltimore, Maryland
Manuel O. Diaz, M.D.
University of Chicago
Chicago, Illinois
James R. Feramisco, Ph.D.
University of California, San Diego
La Jolla, California
Daniel Fults, M.D.
University of Utah
Salt Lake City, Utah
Joseph Ilan, M.D., Ph.D.
Case Western Reserve University
Cleveland, Ohio
Mark A. Israel, M.D.
University of California, San Francisco
San Francisco, California
C. David James, Ph.D.
Emory University School of Medicine
Atlanta, Georgia
Paul Kleihues, M.D.
University of Zurich
Zurich, Switzerland
Robert. L. Martuza, M.D.
Georgetown University Medical Center
Washington, District of Columbia
Ronald McKay, Ph.D.
Massachusetts Institute of Technology
Cambridge, Massachusetts
Ricardo Miledi, M.D., Ph.D.
University of California, Irvine,
Irvine, California
Mark Noble, Ph.D.
Ludwig Institute for Cancer Research
London, United Kingdom
Michael G. Rosenfeld, M.D.
University of California, San Diego
La Jolla, California
Emmett V. Schmidt, M.D.
Harvard Medical Center
Boston, Massachusetts
Bernd Seizinger, M.D., Ph.D.
Bristol-Myers Squibb Pharmaceutical Research Institute
Princeton, New Jersey
Bert Vogelstein, M.D. - Chairperson
Johns Hopkins Oncology Center
Baltimore, Maryland
I. Bernard Weinstein, M.D.
Columbia University
New York, New York
Bengt Westermark, Ph.D.
University of Uppsala
Uppsala, Sweden
Manfred Westphal, M.D.
University Hospital of Eppendorf
Hamburg, Germany
Charles B. Wilson, M.D.
University of California, San Francisco
San Francisco, California